Takeda’s Post

"Eyes on the Prize: Takeda's Latest Pivot🔄💡 In an industry where agility is king, Takeda's bold move to streamline and sharpen its focus is a play we should all watch closely. With patents expiring and the financial landscape shifting, Takeda is cutting the chaff to reveal the wheat—one well-organized workforce and a leaner pipeline geared towards profitability. Their latest fiscal year report isn't just numbers—it's a strategy unveiling. Think trimming R&D while amplifying late-stage assets with the potential to be heavy hitters in the sales department. But it's not just about cuts—it's strategic reinvestment. Data, digital, and tech aren't just buzzwords; they're the fertile ground Takeda is betting on. Meanwhile, external spending is on the chopping block, sharpening Takeda's competitive edge. The message to decision-makers and tech trailblazers in MedTech and biopharma? Adaptability and precision are your best allies. Whether in the boardroom or the lab, turning challenges into growth opportunities is what sets industry leaders apart. Let's talk about how this level of strategic fine-tuning can elevate your game to the next level.📈 #Pharmaceuticals #Innovation #BusinessStrategy"

Who are the Top 10 Companies Shaping Healthcare Through Investments? Our latest analysis highlights the trailblazers transforming healthcare, from Pre-seed to IPO, through strategic investments. 💡 Key Insights: - Alphabet Inc. Inc. takes the lead with 145 investments, underscoring its commitment to healthcare innovation. - Novartis follows closely with 114 investments. - Big Pharma players like Merck (98), Johnson & Johnson (88), and Pfizer (82) maintain strong momentum. - GSK (77) from the UK, alongside US leaders like GE HealthCare (63), Kaiser Permanente (61), and Mayo Clinic (59), bring diversity to the mix. - Eli Lilly and Company closes the list with 57 investments. 🚀 Were these rankings in line with your expectations? Does it surprise you that a tech giant like Alphabet Inc. is at the forefront? Stay tuned for Part II, where we’ll dive into the strategies behind these investments. In the meantime, explore more insights from our team via the link below!

Who are the Top 10 companies by number of investments in Healthcare Organizations? Our latest analysis reveals the leaders shaping the future of healthcare through strategic investments across stages from Pre-seed to IPO. 💡 Key highlights: - Alphabet Inc. leads with 145 investments, showcasing its commitment to healthcare innovation. - Novartis follows with 114 investments. - Pharma giants like Merck (98), Johnson & Johnson (88), and Pfizer (82) remain active players. - UK-based GSK (77) and US leaders like GE (63), Kaiser Permanente (61), and Mayo Clinic (59) diversify the list. - Eli Lilly and Company rounds out the top 10 with 57 investments. Were these rankings what you expected? Did it surprise you that a tech giant like Alphabet Inc. is leading the charge in healthcare investments? We’ll dive deeper into their investment strategies in Part II—stay tuned! Meanwhile, explore more of our team's insights through the link below.

Achieving launch excellence is crucial for companies of all sizes. Despite advancements, 40-50% of recent biopharmaceutical product launches have underperformed. However, opportunities abound for those leveraging sophisticated, digitally forward solutions to enhance precision and efficiency in launches. As Emily Mandell and Kevin Young highlight in their article, "Using Sophisticated Digital-Forward Solutions to Drive Launch Excellence," these strategies hold great potential for improving launch outcomes.  Digital solutions can add value well before a product hits the market, shaping market readiness, customer engagement, and data-driven decision-making. By utilizing AI and connected analytics, companies can better target customers, personalize messaging, streamline patient care, and adapt launch strategies swiftly. Lidia Fonseca, Chief Digital and Technology Officer at Pfizer, highlighted how the company is leveraging digital innovation to streamline operations, from accelerating drug discovery to improving patient and customer experiences. In one of One Vision Health's earlier posts, we shared how video content makes a real impact—it boosts healthcare professionals' understanding by 40%, reduces follow-up questions by 30%, and makes complex data 50% more engaging. Plus, video helps align teams internally and educates externally, making everything work smoother. To achieve both launch sophistication and scale, companies must align key stakeholders across marketing, medical, market access, and analytics teams. By setting clear strategic priorities and adopting pre-vetted digital solutions, organizations can ensure successful, innovative launches. As the industry shifts to a constant launch mode, those capitalizing on digital capabilities at scale will thrive in this dynamic market. Image source: ZS. (May 15, 2024). Pharma Product Launch Excellence: How Digital Solutions Help Companies Lead in a Dynamic Market. #DigitalTransformation #PharmaInnovation #HealthTech #PatientCentricity #Healthcare  

What specialized diagnostics taught me about healthcare innovation: ☢️ 3 Key lessons from launching new radiopharmaceutical products: 1. Speed matters, but precision wins! • In time-sensitive diagnostics, we achieved >90% on-time delivery while maintain perfect quality • Lesson: Even under pressure, quality processes drive sustainable success 2. Data tells stories • Tracking production metrics across two different sites I’ve managed revealed unexpected patterns • Led to ~10% cost reduction through batch optimization 3. Innovation needs champions at every level • From techs to physicians, every role impacts success, even the couriers! • Cross-functional alignment drove 26% customer growth with the help of clinical account execs What innovation lessons has your specialized field taught you? #HealthcareInnovation #DiagnosticMedicine #Leadership

🌍 Leading Innovation Through Collaboration in Pharma! 💊✨ As the Head of Engineering at AbbVie, I've seen firsthand how collaboration fuels innovation and drives us toward our mission of improving lives globally. 🔍 Here’s why collaboration is essential in our industry: 💡 Diverse Insights: By bringing together engineers, scientists, and industry experts, we harness a wealth of perspectives that spark groundbreaking ideas. 🔧 Accelerated Problem-Solving: Complex challenges in pharma require innovative solutions. Working together enables us to tackle issues more effectively and efficiently. 🌐 Expanding Horizons: Collaboration transcends borders. Partnering with teams worldwide allows us to leverage unique expertise and technologies that elevate our projects. 🤝 Join the Conversation: How has collaboration transformed your work in the pharmaceutical industry? I’d love to hear your stories and insights! Share in the comments below! 👇 Together, let’s continue to push the boundaries of what’s possible in healthcare! 🚀 #Pharma #Engineering #Collaboration #Innovation #Leadership #GlobalHealth

Customer centricity is coming: How pharma companies of all sizes are making it happen With fewer blockbuster products hitting the market, a focus on treating more narrow patient populations, and more competition than ever before, pharma companies’ ability to drive success through their products alone is shrinking. As a result, companies are realizing they need to capture more value—both with and for their customers—a prospect that’s caused the industry to rethink the selling model and adopt a more customer-centric mindset. #pharma #customercentricity https://lnkd.in/dJJeuZ5G

A layer of purpose can turn individual actions into unified outcomes. For pharma teams, connecting around purpose brings collaboration, alignment, and impact. Ready to see how purpose can change your team’s landscape? Reach out, and let’s explore together. www.excellerate.ca #PowerofPurpose #TransformationalLeadership #PharmaTeams

In today's fast-paced business environment, effective reporting is essential. The Five Ws—Who, What, Where, When, and Why—are your strategic tools for making data-driven decisions. Learn how mastering these fundamentals can propel growth across industries in our latest blog! https://lnkd.in/ee3KuBm2 #DataReporting, #MarketingStrategy, #BusinessAnalytics, #Finance, #Healthcare, #Pharmaceuticals, #Technology, #Telecommunications, #RealEstate, #MarketingManagement, #Insights, #DataDriven, #BusinessGrowth, #StakeholderEngagement, #ReportingTechniques, #Analytics, #DigitalMarketing, #MarketingStudents, #EffectiveReporting, #Leadership, #ContinuousImprovement

Is '𝐭𝐡𝐨𝐮𝐠𝐡𝐭 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩' just another buzzword in the pharma industry echo chamber? 🤔 Every company claims to lead, but few truly influence the field. Are we stuck in a loop of repetitive innovations and self-congratulatory breakthroughs? 🚀 Dive into our latest blog: '𝗙𝗼𝗿𝗴𝗲𝘁 𝗧𝗵𝗼𝘂𝗴𝗵𝘁 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽: 𝗔 𝟲-𝗦𝘁𝗲𝗽 𝗚𝘂𝗶𝗱𝗲 𝗳𝗼𝗿 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗧𝗲𝗮𝗺𝘀 𝘁𝗼 𝗦𝘁𝗮𝗻𝗱 𝗢𝘂𝘁 𝗶𝗻 𝗮 𝗦𝗲𝗮 𝗼𝗳 𝗦𝗮𝗺𝗲𝗻𝗲𝘀𝘀'. We challenge the status quo and redefine what it means to drive genuine change in healthcare. https://shorturl.at/Vhr52 👉 Read more to discover are you leading or just following? Comment below with your thoughts and experiences.